Your search for non small cell lung cancer returned 2 results

Higher major pathological response seen for patients with resectable NSCLC treated with combo versus durvalumab alone.

New research suggests that mRNA COVID-19 vaccines can elevate PD-L1 expression levels in patients with advanced non-small cell lung cancer.